Vivo Bio Tech

{
  "main_header": {
    "sid": 650679,
    "name": "Vivo Bio Tech",
    "stock_name": "Vivo Bio Tech",
    "full_name": "Vivo Bio Tech Ltd.",
    "name_url": "stocks-analysis/vivo-bio-tech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "28.48",
    "chg": 0.36,
    "chgp": "1.28%",
    "dir": 1,
    "prev_price": "28.12",
    "mcapval": "63.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 511509,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE380K01017",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "13.06 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivo-bio-tech-650679-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivo Bio Tech Ltd. is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-ltd-is-rated-strong-sell-3817580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivoBioTechLtd_mojoScore_3817580.png",
        "date": "2026-02-03 10:16:54",
        "description": "Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vivo Bio Tech Ltd. Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivo-bio-tech-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3816457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivoBioTechLtd_priceRelatedfactors_3816457.png",
        "date": "2026-02-02 11:22:50",
        "description": "Vivo Bio Tech Ltd., a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.25.2 today, marking a significant decline in its stock price amid a broader market environment showing mixed signals. The stock’s performance reflects ongoing pressures, with a notable underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Vivo Bio Tech Ltd. Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3795440",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VivoBioTechLtd_mojoScore_3795440.png",
        "date": "2026-01-20 08:12:47",
        "description": "Vivo Bio Tech Ltd., a player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 19 Jan 2026. This revision reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and a valuation that, while attractive, is overshadowed by the company’s faltering fundamentals and poor market performance relative to benchmarks like the Sensex."
      },
      {
        "title": "Vivo Bio Tech Ltd. is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-ltd-is-rated-strong-sell-3784304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VivoBioTechLtd_mojoScore_3784304.png",
        "date": "2026-01-07 10:10:55",
        "description": "Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Vivo Bio Tech Ltd. is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-ltd-is-rated-strong-sell-3769528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivoBioTechLtd_mojoScore_3769528.png",
        "date": "2025-12-25 15:13:16",
        "description": "Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vivo Bio Tech . Falls to 52-Week Low of Rs.25.21 Amidst Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivo-bio-tech-stock-falls-to-52-week-low-of-rs2521-amidst-continued-downtrend-3751734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivoBioTech_priceRelatedfactors_3751734.png",
        "date": "2025-12-08 15:29:37",
        "description": "Vivo Bio Tech . has reached a new 52-week low of Rs.25.21 today, marking a significant decline in its stock price amid broader sector pressures and company-specific performance factors. The stock has recorded a three-day consecutive fall, accumulating a near 10% loss over this period, underperforming the Pharmaceuticals & Biotechnology sector by 1.92% on the day."
      },
      {
        "title": "Vivo Bio Tech . Falls to 52-Week Low of Rs.25.21 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivo-bio-tech-stock-hits-52-week-low-amidst-continued-downtrend-3751733",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivoBioTech_priceRelatedfactors_3751733.png",
        "date": "2025-12-08 15:29:22",
        "description": "Vivo Bio Tech . has reached a new 52-week low of Rs.25.21 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry."
      },
      {
        "title": "Vivo Bio Tech Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-trends-3749775",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivoBioTech_mojoScore_3749775.png",
        "date": "2025-12-06 10:10:33",
        "description": "Vivo Bio Tech, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. The stock’s recent assessment highlights a combination of subdued growth metrics, valuation appeal, and bearish technical signals, contributing to a shift in market perspective."
      },
      {
        "title": "Why is Vivo Bio Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vivo-bio-tech-fallingrising-3749459",
        "imagepath": "",
        "date": "2025-12-06 01:10:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Volatility</strong></p>\n<p>Despite opening the day with a positive gap of 2.09%, the stock failed to sustain gains and experienced a sharp intraday fall, hitting a new 52-week low of ₹27.16. The share price fluctuated within a wide range of ₹3.61, demonstrating high volatility with an intraday volatility of 6.21%. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. The stock has now declined for two consecutive days, losing nearly 7% in that period, and underperformed its sector by 6.19% on the day.</p>\n<p><strong>Long-Term Underperformance Against Benchmarks</strong></p>\n<p>Vivo Bio Tech’s share price has consistently lagged behind key market indices over multiple time horizons. ..."
      }
    ],
    "total": 89,
    "sid": "650679",
    "stock_news_url": "https://www.marketsmojo.com/news/vivo-bio-tech-650679"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting To Be Held On Friday February 13 2026",
      "datetime": "02-Feb-2026",
      "details": "Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "16-Jan-2026",
      "details": "please find enclosed",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "09-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kompella Lopa Mudra",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vivo Bio Tech Ltd. is Rated Strong Sell

2026-02-03 10:16:54

Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Vivo Bio Tech Ltd. Stock Hits 52-Week Low Amidst Continued Downtrend

2026-02-02 11:22:50

Vivo Bio Tech Ltd., a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.25.2 today, marking a significant decline in its stock price amid a broader market environment showing mixed signals. The stock’s performance reflects ongoing pressures, with a notable underperformance relative to its sector and benchmark indices.

Read full news article

Vivo Bio Tech Ltd. Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-01-20 08:12:47

Vivo Bio Tech Ltd., a player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 19 Jan 2026. This revision reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and a valuation that, while attractive, is overshadowed by the company’s faltering fundamentals and poor market performance relative to benchmarks like the Sensex.

Read full news article

Vivo Bio Tech Ltd. is Rated Strong Sell

2026-01-07 10:10:55

Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Vivo Bio Tech Ltd. is Rated Strong Sell

2025-12-25 15:13:16

Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Vivo Bio Tech . Falls to 52-Week Low of Rs.25.21 Amidst Sector Underperformance

2025-12-08 15:29:37

Vivo Bio Tech . has reached a new 52-week low of Rs.25.21 today, marking a significant decline in its stock price amid broader sector pressures and company-specific performance factors. The stock has recorded a three-day consecutive fall, accumulating a near 10% loss over this period, underperforming the Pharmaceuticals & Biotechnology sector by 1.92% on the day.

Read full news article

Vivo Bio Tech . Falls to 52-Week Low of Rs.25.21 Amidst Continued Downtrend

2025-12-08 15:29:22

Vivo Bio Tech . has reached a new 52-week low of Rs.25.21 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry.

Read full news article

Vivo Bio Tech Sees Revision in Market Evaluation Amidst Challenging Financial Trends

2025-12-06 10:10:33

Vivo Bio Tech, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. The stock’s recent assessment highlights a combination of subdued growth metrics, valuation appeal, and bearish technical signals, contributing to a shift in market perspective.

Read full news article

Why is Vivo Bio Tech falling/rising?

2025-12-06 01:10:11

Recent Price Movements and Volatility

Despite opening the day with a positive gap of 2.09%, the stock failed to sustain gains and experienced a sharp intraday fall, hitting a new 52-week low of ₹27.16. The share price fluctuated within a wide range of ₹3.61, demonstrating high volatility with an intraday volatility of 6.21%. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. The stock has now declined for two consecutive days, losing nearly 7% in that period, and underperformed its sector by 6.19% on the day.

Long-Term Underperformance Against Benchmarks

Vivo Bio Tech’s share price has consistently lagged behind key market indices over multiple time horizons. ...

Read full news article

View All News